Trevena Inc. (TRVN): Revenue Growth QoQ

Corporate company logo of Trevena Inc (TRVN)

Trevena, Inc. is currently in an operational defense mode, attempting to overcome challenges with the commercialization of its primary analgesic. The development of modern painkillers for inpatient settings ensures steady sales through hospital formularies. Revenues are based on the treatment of neurological pathologies and acute pain. The quarterly revenue growth rate reflects expanding operations, with the indicator standing at -89.70.

TRVN (Trevena Inc) Quarterly Sales Growth history from 07/04/2022 to 10/19/2024

Trevena Inc. (TRVN) - metric breakdowns and financial figures

- stock price and consensus target price:
- stock exchange capitalization data:
- cash and cash flow metrics:
General company analysis:Trevena, Inc. - TRVN
Flagship merchandise of Trevena

To assess the financial stability of Trevena, Inc. (TRVN), analyzing cash flow dynamics is critical, as calculating the relative change in quarterly sales helps identify business scaling rates prior to a market revaluation. The current level of quarter-over-quarter revenue growth reflects the company's ability to generate income amid geopolitical restrictions and logistical disruptions that are slowing the certification of neurological drugs and the conduct of international trials.

Competitor analysis for Trevena, Inc.

BIIB - Revenue Growth QoQ|NBIX (Neurocrine Biosciences) - Sales Growth QoQ|RGC: Quarterly Revenue Growth|Quarterly Revenue Growth Rate Axsome (AXSM)|Revenue Growth QoQ ACADIA Pharmaceuticals Inc|Quarterly Sales Growth Xenon Pharmaceuticals Inc (XENE)|Quarterly Revenue Growth VKTX|Quarterly Revenue Growth supernus.com (SUPN)|Revenue Growth QoQ Catalyst Pharmaceuticals, Inc. CPRX|DNLI (Denali Therapeutics Inc.) - Revenue Dynamics QoQ|Harmony Corp - Quarterly Revenue Growth|BHVN: Revenue Growth QoQ|AMLX: Quarterly Revenue Growth|TRVI: Sales Change QoQ|Revenue Growth QoQ Praxis Medicines|Quarterly Revenue Growth Rate Anavex AVXL|Revenue Growth QoQ CeriBell Corp (CBLL)|Sales Change QoQ PRTA|Quarterly Revenue Growth ALEC (Alector)|Annexon (ANNX) - Quarterly Revenue Growth Rate|OMER - Revenue Growth QoQ|NGNE (Neurogene) - Sales Growth QoQ|ACIU: Quarterly Revenue Growth|VYGR - Quarterly Sales Growth Rate|Revenue Growth QoQ Neumora Therapeutics, Inc.|Sales Growth QoQ SCLX (Scilex)|Quarterly Sales Growth TVGN (Tevogen Bio)|Quarterly Revenue Growth Alpha Cognition Inc (ACOG)|Quarterly Revenue Growth CGTX (cogrx.com)|Quarterly Sales Growth Rate Inhibikase Pharma (IKT)|SAVA: Quarterly Sales Growth|Quarterly Sales Growth Rate Assertio ASRT|COYA (coyatherapeutics.com) - Quarterly Sales Growth|Sales Growth QoQ VTGN|OVID (Ovid Therapeutics) - Quarterly Revenue Growth|Acumen Pharmaceuticals, Inc (ABOS) - Quarterly Sales Growth Rate|Revenue Growth QoQ CervoMed, Inc. (CRVO)|ATHE - Quarterly Revenue Growth Rate|Quarterly Revenue Growth CLNN (Clene Inc.)|Quarterly Sales Growth Rate PepGen Inc. (PEPG)|JUNS - Revenue Growth QoQ|Quarterly Revenue Growth Rate Relmada Corp|ANVS (Annovis Bio, Inc.) - Quarterly Sales Growth|Grace Tx (GRCE) - Quarterly Revenue Growth|Quarterly Sales Growth AIFF|Quarterly Revenue Growth anewmeds.com|Revenue Growth QoQ NeuroSense Therapeutics (NRSN)|RVPH (Reviva Pharmaceuticals Holdings) - Quarterly Revenue Increase|MetaVia - Quarterly Sales Growth|NRXS: Sales Growth QoQ|Helius Medical Technologies, Inc. - Quarterly Revenue Growth|PASG: Revenue Growth QoQ|Neuphoria (NEUP) - Revenue Growth QoQ|Minerva Neurosciences - Quarterly Revenue Increase|ATHA (Athira Pharma, Inc.) - Quarterly Revenue Growth|Quarterly Revenue Growth Rate addextherapeutics.com ADXN|Quarterly Sales Growth ALZN (Alzamend Neuro Inc.)|CYCN (Cyclerion Therapeutics, Inc.) - Quarterly Revenue Increase|Quarterly Revenue Growth PTIX (Protagenic)|Quarterly Revenue Growth pasitheaclinics.com KTTA|CRGT - Revenue Growth QoQ|Quarterly Revenue Increase ATXI (Avenue Therapeutics)|BCLI: Quarterly Revenue Growth|Cara Therapeutics - Quarterly Revenue Increase|Revenue Growth QoQ Chromocell Therapeutics Corporation|Quarterly Revenue Growth Eliem Therapeutics Inc.|Revenue Growth QoQ Intra-Cellular Therapies, Inc. (ITCI)|LBPH (Longboard Pharmaceuticals) - Quarterly Revenue Increase|Quarterly Revenue Growth MRNS (marinuspharma.com)|NKGN: Sales Growth QoQ|NRBO - Revenue Growth QoQ|SAGE - Quarterly Revenue Growth|Synaptogenix (SNPX) - Revenue Growth QoQ|Quarterly Revenue Growth Rate Vigil Neuroscience (VIGL)|Revenue Growth QoQ Anew Medical, Inc.|CERE (Cerevel Therapeutics, Inc.) - Sales Change QoQ